2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚结构式
|
常用名 | 2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚 | 英文名 | Latrepirdine |
---|---|---|---|---|
CAS号 | 3613-73-8 | 分子量 | 319.443 | |
密度 | 1.1±0.1 g/cm3 | 沸点 | 505.7±50.0 °C at 760 mmHg | |
分子式 | C21H25N3 | 熔点 | 115-116 °C | |
MSDS | N/A | 闪点 | 259.7±30.1 °C |
用途Latrepirdine is an orally-available drug, approved in Russia for use as a non-selective antihistamine, that has shown promise in the treatment of neurodegenerative diseases, including Alzheimer’s and Huntington’s disease. In addition to reported activity in preventing the onset and progression of disease by being neuroprotective, dimebolin appears to promote clinical improvement by increasing cognitive function. At the cellular level, dimebolin appears to have diverse effects, inhibiting the neurotoxic action of β-amyloid and blocking L-type calcium channels,5 inhibiting NMDA-type glutamate receptors, and preventing mitochondrial leakage. |
中文名 | 2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-b]吲哚 |
---|---|
英文名 | 2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole |
中文别名 | 2,3,4,5-四氢-2,8-二甲基-5-[2-(6-甲基吡啶-3-基)乙基]-1H-吡啶并[4,3-B]吲哚 | 丹吡芙蓉 |
英文别名 | 更多 |
密度 | 1.1±0.1 g/cm3 |
---|---|
沸点 | 505.7±50.0 °C at 760 mmHg |
熔点 | 115-116 °C |
分子式 | C21H25N3 |
分子量 | 319.443 |
闪点 | 259.7±30.1 °C |
精确质量 | 319.204834 |
PSA | 21.06000 |
LogP | 3.96 |
外观性状 | 棕褐色固体 |
蒸汽压 | 0.0±1.3 mmHg at 25°C |
折射率 | 1.629 |
储存条件 | 室温 |
危害码 (欧洲) | Xi |
---|
9-(2-(2-Methyl-5-pyridyl)ethyl)-3,6-dimethyl-1,2,3,4-tetrahydro-γ-carboline |
2,8-Dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
Dimebolin |
Dimebon |
1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]- |
aka latrepiridine |
Dimebone |
Latrepirdine |
Dimeboline |
2,8-Dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
2,8-Dimethyl-5-[2-(6-methyl-pyridin-3-yl)-ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole |
Preparation 84 |